Stacy Pryts

Stacy Pryts is a seasoned professional in the field of pharmacology and oncology with extensive experience across various organizations. Currently, Stacy serves as Associate Director at AstraZeneca, leading in vivo pharmacology studies in the early oncology group to support immuno-oncology program transitions. Previously, Stacy held positions as Senior Scientist and Scientist at AstraZeneca, focusing on the design and implementation of cell-based assays. Prior experience includes roles as Program Manager at Quintiles, Associate Scientist at MedImmune, and Biologist at the NIH, where Stacy honed skills in assay design, in vivo mouse modeling, and various molecular biology techniques. Educational qualifications include a Master's degree in Biomedical Science with a focus on immunology from Hood College and a Bachelor's degree in Biology from McDaniel College.